Free Trial

HealthEquity (HQY) Stock Price, News & Analysis

HealthEquity logo
$88.74 +1.69 (+1.94%)
Closing price 04:00 PM Eastern
Extended Trading
$84.00 -4.74 (-5.34%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HealthEquity Stock (NASDAQ:HQY)

Key Stats

Today's Range
$85.39
$88.94
50-Day Range
$84.32
$114.51
52-Week Range
$65.01
$115.59
Volume
676,849 shs
Average Volume
734,160 shs
Market Capitalization
$7.68 billion
P/E Ratio
81.41
Dividend Yield
N/A
Price Target
$112.58
Consensus Rating
Buy

Company Overview

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Remove Ads

HealthEquity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

HQY MarketRank™: 

HealthEquity scored higher than 84% of companies evaluated by MarketBeat, and ranked 167th out of 927 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HealthEquity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    HealthEquity has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about HealthEquity's stock forecast and price target.
  • Earnings Growth

    Earnings for HealthEquity are expected to grow by 22.41% in the coming year, from $2.32 to $2.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HealthEquity is 81.41, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HealthEquity is 81.41, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.12.

  • Price to Earnings Growth Ratio

    HealthEquity has a PEG Ratio of 1.60. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    HealthEquity has a P/B Ratio of 3.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about HealthEquity's valuation and earnings.
  • Percentage of Shares Shorted

    4.87% of the float of HealthEquity has been sold short.
  • Short Interest Ratio / Days to Cover

    HealthEquity has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in HealthEquity has recently decreased by 4.18%, indicating that investor sentiment is improving.
  • Dividend Yield

    HealthEquity does not currently pay a dividend.

  • Dividend Growth

    HealthEquity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.87% of the float of HealthEquity has been sold short.
  • Short Interest Ratio / Days to Cover

    HealthEquity has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in HealthEquity has recently decreased by 4.18%, indicating that investor sentiment is improving.
  • News Sentiment

    HealthEquity has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for HealthEquity this week, compared to 8 articles on an average week.
  • Search Interest

    11 people have searched for HQY on MarketBeat in the last 30 days. This is an increase of 267% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $639,918.00 in company stock.

  • Percentage Held by Insiders

    Only 2.20% of the stock of HealthEquity is held by insiders.

  • Percentage Held by Institutions

    99.55% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about HealthEquity's insider trading history.
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HQY Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

HQY Stock Analysis - Frequently Asked Questions

HealthEquity's stock was trading at $95.95 at the beginning of the year. Since then, HQY stock has decreased by 7.5% and is now trading at $88.74.
View the best growth stocks for 2025 here
.

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Monday, December, 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by $0.12. HealthEquity had a trailing twelve-month return on equity of 9.70% and a net margin of 8.41%.

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HealthEquity investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Netflix (NFLX), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

Last Earnings
12/09/2024
Today
4/02/2025
Next Earnings (Estimated)
6/02/2025
Fiscal Year End
1/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
Business Services
Current Symbol
NASDAQ:HQY
Employees
3,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$112.58
High Stock Price Target
$130.00
Low Stock Price Target
$94.00
Potential Upside/Downside
+27.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
12 Analysts

Profitability

Trailing P/E Ratio
81.23
Forward P/E Ratio
38.16
P/E Growth
1.6
Net Income
$55.71 million
Pretax Margin
10.07%

Debt

Sales & Book Value

Annual Sales
$1.20 billion
Cash Flow
$2.71 per share
Price / Cash Flow
32.67
Book Value
$23.72 per share
Price / Book
3.73

Miscellaneous

Free Float
84,756,000
Market Cap
$7.66 billion
Optionable
Optionable
Beta
0.62

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:HQY) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners